Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:20513072rdf:typepubmed:Citationlld:pubmed
pubmed-article:20513072lifeskim:mentionsumls-concept:C0220847lld:lifeskim
pubmed-article:20513072lifeskim:mentionsumls-concept:C0019682lld:lifeskim
pubmed-article:20513072lifeskim:mentionsumls-concept:C0205653lld:lifeskim
pubmed-article:20513072lifeskim:mentionsumls-concept:C0021747lld:lifeskim
pubmed-article:20513072lifeskim:mentionsumls-concept:C0035525lld:lifeskim
pubmed-article:20513072lifeskim:mentionsumls-concept:C0036043lld:lifeskim
pubmed-article:20513072lifeskim:mentionsumls-concept:C0439661lld:lifeskim
pubmed-article:20513072pubmed:issue7lld:pubmed
pubmed-article:20513072pubmed:dateCreated2010-5-31lld:pubmed
pubmed-article:20513072pubmed:abstractTextLimited evidence is available currently regarding the efficacy and safety of pegylated interferon (PEG-IFN) and ribavirin in patients co-infected perinatally with human immunodeficiency virus (HIV) and hepatitis C virus (HCV). No information is available on whether or not these patients should be treated earlier for infection with HCV. This report describes four patients with HIV and HCV co-infection acquired perinatally, who were treated with PEG-IFN and ribavirin for chronic viral hepatitis caused by HCV.lld:pubmed
pubmed-article:20513072pubmed:languageenglld:pubmed
pubmed-article:20513072pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20513072pubmed:citationSubsetIMlld:pubmed
pubmed-article:20513072pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20513072pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20513072pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20513072pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20513072pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20513072pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20513072pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20513072pubmed:statusMEDLINElld:pubmed
pubmed-article:20513072pubmed:monthJullld:pubmed
pubmed-article:20513072pubmed:issn1096-9071lld:pubmed
pubmed-article:20513072pubmed:authorpubmed-author:ViscoliClaudi...lld:pubmed
pubmed-article:20513072pubmed:authorpubmed-author:BernardiniCla...lld:pubmed
pubmed-article:20513072pubmed:authorpubmed-author:Di...lld:pubmed
pubmed-article:20513072pubmed:authorpubmed-author:RossoRaffaell...lld:pubmed
pubmed-article:20513072pubmed:authorpubmed-author:MikulskaMalgo...lld:pubmed
pubmed-article:20513072pubmed:authorpubmed-author:NiccoElenaElld:pubmed
pubmed-article:20513072pubmed:copyrightInfo(c) 2010 Wiley-Liss, Inc.lld:pubmed
pubmed-article:20513072pubmed:issnTypeElectroniclld:pubmed
pubmed-article:20513072pubmed:volume82lld:pubmed
pubmed-article:20513072pubmed:ownerNLMlld:pubmed
pubmed-article:20513072pubmed:authorsCompleteYlld:pubmed
pubmed-article:20513072pubmed:pagination1110-4lld:pubmed
pubmed-article:20513072pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:20513072pubmed:meshHeadingpubmed-meshheading:20513072...lld:pubmed
pubmed-article:20513072pubmed:meshHeadingpubmed-meshheading:20513072...lld:pubmed
pubmed-article:20513072pubmed:meshHeadingpubmed-meshheading:20513072...lld:pubmed
pubmed-article:20513072pubmed:meshHeadingpubmed-meshheading:20513072...lld:pubmed
pubmed-article:20513072pubmed:meshHeadingpubmed-meshheading:20513072...lld:pubmed
pubmed-article:20513072pubmed:meshHeadingpubmed-meshheading:20513072...lld:pubmed
pubmed-article:20513072pubmed:meshHeadingpubmed-meshheading:20513072...lld:pubmed
pubmed-article:20513072pubmed:meshHeadingpubmed-meshheading:20513072...lld:pubmed
pubmed-article:20513072pubmed:meshHeadingpubmed-meshheading:20513072...lld:pubmed
pubmed-article:20513072pubmed:meshHeadingpubmed-meshheading:20513072...lld:pubmed
pubmed-article:20513072pubmed:meshHeadingpubmed-meshheading:20513072...lld:pubmed
pubmed-article:20513072pubmed:meshHeadingpubmed-meshheading:20513072...lld:pubmed
pubmed-article:20513072pubmed:meshHeadingpubmed-meshheading:20513072...lld:pubmed
pubmed-article:20513072pubmed:meshHeadingpubmed-meshheading:20513072...lld:pubmed
pubmed-article:20513072pubmed:meshHeadingpubmed-meshheading:20513072...lld:pubmed
pubmed-article:20513072pubmed:meshHeadingpubmed-meshheading:20513072...lld:pubmed
pubmed-article:20513072pubmed:year2010lld:pubmed
pubmed-article:20513072pubmed:articleTitleSafety and efficacy of pegylated interferon and ribavirin in adolescents with human immunodeficiency virus and hepatitis C virus acquired perinatally.lld:pubmed
pubmed-article:20513072pubmed:affiliationInfectious Diseases Clinic, University of Genoa, San Martino Hospital, Genoa, Italy.lld:pubmed
pubmed-article:20513072pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:20513072pubmed:publicationTypeCase Reportslld:pubmed